Estée Lauder Companies (EL) Short Interest Ratio & Short Volume → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free EL Stock Alerts $123.36 +2.62 (+2.17%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Estée Lauder Companies Short Interest DataCurrent Short Interest4,190,000 sharesPrevious Short Interest4,670,000 sharesChange Vs. Previous Month-10.28%Dollar Volume Sold Short$569.84 millionShort Interest Ratio1.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares358,564,000 sharesPercentage of Shares Shorted1.17%Today's Trading Volume2,969,244 sharesAverage Trading Volume2,700,492 sharesToday's Volume Vs. Average110% Short Selling Estée Lauder Companies ? Sign up to receive the latest short interest report for Estée Lauder Companies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEL Short Interest Over TimeEL Days to Cover Over TimeEL Percentage of Float Shorted Over Time Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> Estée Lauder Companies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20244,190,000 shares $569.84 million -10.3%N/A1.6 $136.00 4/30/20244,670,000 shares $685.23 million +1.5%N/A1.8 $146.73 4/15/20244,600,000 shares $631.26 million -12.1%N/A1.8 $137.23 3/31/20245,230,000 shares $806.20 million -11.2%N/A1.9 $154.15 3/15/20245,890,000 shares $881.97 million +9.5%N/A2.2 $149.74 2/29/20245,380,000 shares $798.77 million -0.7%N/A1.9 $148.47 Get the Latest News and Ratings for EL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estée Lauder Companies and its competitors with MarketBeat's FREE daily newsletter. 2/15/20245,420,000 shares $787.63 million +0.6%N/A1.9 $145.32 1/31/20245,390,000 shares $711.43 million +28.0%N/A1.8 $131.99 1/15/20244,210,000 shares $567.55 million +1.0%1.8%1.4 $134.81 12/31/20234,170,000 shares $609.86 million +4.5%1.8%1.5 $146.25 12/15/20233,990,000 shares $573.12 million -3.9%1.7%1.4 $143.64 11/30/20234,150,000 shares $529.75 million -19.3%1.8%1.5 $127.65 11/15/20235,140,000 shares $648.00 million +27.2%2.2%2 $126.07 10/31/20234,040,000 shares $520.63 million +20.2%1.8%1.5 $128.87 10/15/20233,360,000 shares $462.60 million -3.7%1.5%1.4 $137.68 9/30/20233,490,000 shares $504.48 million +10.8%1.5%1.4 $144.55 9/15/20233,150,000 shares $490.46 million -10.0%1.4%1.3 $155.70 8/31/20233,500,000 shares $561.86 million +14.4%1.5%1.4 $160.53 8/15/20233,060,000 shares $500.16 million -10.0%1.3%1.2 $163.45 7/31/20233,400,000 shares $612 million +25.9%1.5%1.4 $180.00 7/15/20232,700,000 shares $522.80 million +2.3%1.2%1.1 $193.63 6/30/20232,640,000 shares $518.44 million +16.8%1.1%1.2 $196.38 6/15/20232,260,000 shares $450.67 million -32.3%1.0%1 $199.41 5/31/20233,340,000 shares $614.66 million +1.8%1.5%1.7 $184.03 5/15/20233,280,000 shares $659.90 million +29.6%1.4%1.9 $201.19 4/30/20232,530,000 shares $624.20 million -12.2%1.1%1.5 $246.72 4/15/20232,880,000 shares $731.55 million +1.8%1.3%2 $254.01 3/31/20232,830,000 shares $697.48 million +11.4%1.2%2 $246.46 3/15/20232,540,000 shares $601.47 million +12.9%1.1%1.8 $236.80 2/28/20232,250,000 shares $546.86 million -14.1%1.0%1.5 $243.05 2/15/20232,620,000 shares $667.18 million -12.4%1.1%1.6 $254.65 1/31/20232,990,000 shares $828.47 million -5.4%1.3%1.7 $277.08 1/15/20233,160,000 shares $844.42 million -15.7%1.4%1.6 $267.22 12/30/20223,750,000 shares $930.41 million +3.9%1.6%1.9 $248.11 12/15/20223,610,000 shares $868.57 million +17.2%1.6%1.8 $240.60 11/30/20223,080,000 shares $726.23 million -10.2%1.3%1.6 $235.79 11/15/20223,430,000 shares $778.54 million +14.0%1.5%1.8 $226.98 10/31/20223,010,000 shares $603.47 million +16.2%1.3%1.7 $200.49 10/15/20222,590,000 shares $542.11 million -2.6%1.1%1.8 $209.31 9/30/20222,660,000 shares $574.29 million +1.1%1.2%2.1 $215.90Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> 9/15/20222,630,000 shares $643.77 million -25.5%1.1%2.1 $244.78 8/31/20223,530,000 shares $897.96 million +11.7%1.5%2.8 $254.38 8/15/20223,160,000 shares $873.33 million -6.2%1.4%2.4 $276.37 7/31/20223,370,000 shares $920.35 million -0.9%1.5%2.3 $273.10 7/15/20223,400,000 shares $834.84 million -0.9%1.5%2.1 $245.54 6/30/20223,430,000 shares $873.52 million +8.5%1.5%2 $254.67 6/15/20223,160,000 shares $768.26 million +35.0%1.4%1.9 $243.12 5/31/20222,340,000 shares $595.88 million -12.4%1.0%1.4 $254.65 5/15/20222,670,000 shares $641.84 million +9.4%1.2%1.6 $240.39 4/30/20222,440,000 shares $644.31 million +7.0%1.1%1.5 $264.06 4/15/20222,280,000 shares $601.62 million +4.1%1.0%1.4 $263.87 3/31/20222,190,000 shares $596.38 million -11.7%1.0%1.3 $272.32 3/15/20222,480,000 shares $642.07 million -12.7%1.1%1.6 $258.90 2/28/20222,840,000 shares $841.58 million +10.1%1.2%1.9 $296.33 2/15/20222,580,000 shares $793.43 million +43.3%1.1%1.8 $307.53 1/31/20221,800,000 shares $561.22 million -3.2%0.8%1.3 $311.79 1/15/20221,860,000 shares $599.01 million -16.2%0.8%1.4 $322.05 12/31/20212,220,000 shares $821.84 million -18.7%1.0%1.8 $370.20 12/15/20212,730,000 shares $996.78 million -12.8%1.2%2.2 $365.12 11/30/20213,130,000 shares $1.04 billion +42.3%1.4%2.6 $332.07 11/15/20212,200,000 shares $765.75 million -6.0%1.0%1.9 $348.07 10/29/20212,340,000 shares $758.93 million +18.2%1.0%2.1 $324.33 10/15/20211,980,000 shares $635.22 million -5.3%0.9%1.9 $320.82 9/30/20212,090,000 shares $626.85 million +25.9%0.9%2.1 $299.93 9/15/20211,660,000 shares $541.58 million -6.2%0.7%1.7 $326.25 8/31/20211,770,000 shares $602.67 million -18.1%0.8%1.8 $340.49 8/13/20212,160,000 shares $705.46 million +14.9%0.9%2.2 $326.60 7/30/20211,880,000 shares $627.60 million +1.1%0.8%1.8 $333.83 7/15/20211,860,000 shares $608.15 million -12.3%0.8%1.6 $326.96 6/30/20212,120,000 shares $674.33 million +22.5%0.9%1.8 $318.08 6/15/20211,730,000 shares $523.86 million -1.7%0.8%1.5 $302.81 5/28/20211,760,000 shares $539.48 million -7.9%0.8%1.4 $306.52 5/14/20211,910,000 shares $555.85 million +7.9%N/A1.4 $291.02 4/30/20211,770,000 shares $560.65 million -2.2%N/A1.2 $316.75 4/15/20211,810,000 shares $550.95 million -13.0%N/A1.3 $304.39 3/31/20212,080,000 shares $613.87 million -22.4%N/A1.5 $295.13 3/15/20212,680,000 shares $775.08 million +14.0%N/A1.8 $289.21 2/26/20212,350,000 shares $680.61 million +23.7%N/A1.7 $289.62 2/12/20211,900,000 shares $550.54 million +17.3%N/A1.4 $289.76 1/29/20211,620,000 shares $397.03 million -19.4%N/A1.2 $245.08 1/15/20212,010,000 shares $502.54 million +4.2%N/A1.6 $250.02 12/31/20201,930,000 shares $506.86 million +12.9%N/A1.6 $262.62 12/15/20201,710,000 shares $423.14 million -25.7%N/A1.4 $247.45 11/30/20202,300,000 shares $565.66 million +46.5%N/A2.1 $245.94 11/15/20201,570,000 shares $400.52 million -12.3%N/A1.4 $255.11 10/30/20201,790,000 shares $399.42 million -22.8%N/A1.5 $223.14 10/15/20202,320,000 shares $516.99 million -8.7%N/A2.1 $222.84 9/30/20202,540,000 shares $554.36 million -0.8%N/A2.2 $218.25 9/15/20202,560,000 shares $557.47 million -20.0%N/A2.1 $217.76 8/31/20203,200,000 shares $709.50 million +20.8%N/A2.5 $221.72Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> 8/14/20202,650,000 shares $562.04 million -4.0%N/A2 $212.09 7/31/20202,760,000 shares $545.21 million +19.5%N/A2 $197.54 7/15/20202,310,000 shares $452.48 million -9.4%N/A1.6 $195.88 6/30/20202,550,000 shares $481.13 million -21.1%N/A1.5 $188.68 6/15/20203,230,000 shares $618.35 million +3.9%N/A1.7 $191.44 5/29/20203,110,000 shares $614.13 million +0.3%N/A1.4 $197.47 5/15/20203,100,000 shares $525.17 million +11.9%N/A1.3 $169.41 4/30/20202,770,000 shares $488.63 million -14.8%N/A1.1 $176.40 4/15/20203,250,000 shares $512.82 million -41.3%N/A1.3 $157.79 3/31/20205,540,000 shares $921.36 million +21.8%N/A2.3 $166.31 3/13/20204,547,500 shares $749.56 million +23.2%2.1%2.4 $164.83 2/28/20203,690,000 shares $532.76 million +6.0%N/A1.9 $144.38 2/14/20203,480,000 shares $652.08 million +5.5%N/A2 $187.38 1/31/20203,300,000 shares $624.66 million -12.0%N/A2.1 $189.29 1/15/20203,750,000 shares $786.83 million +5.0%N/A2.4 $209.82 12/31/20193,570,000 shares $733.06 million +4.4%N/A2.4 $205.34 8/15/20196,440,200 shares $1.29 billion -0.4%3.0%4.8 $200.16 EL Short Interest - Frequently Asked Questions What is Estée Lauder Companies' current short interest? Short interest is the volume of Estée Lauder Companies shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 4,190,000 shares of EL short. Learn More on Estée Lauder Companies' current short interest. What is a good short interest ratio for Estée Lauder Companies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EL shares currently have a short interest ratio of 2.0. Learn More on Estée Lauder Companies's short interest ratio. Which institutional investors are shorting Estée Lauder Companies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Estée Lauder Companies: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, HAP Trading LLC, Twin Tree Management LP, XR Securities LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Caas Capital Management LP, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Estée Lauder Companies' short interest increasing or decreasing? Estée Lauder Companies saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 4,190,000 shares, a drop of 10.3% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Estée Lauder Companies' short interest compare to its competitors? Here is how the short interest of companies compare to Estée Lauder Companies: Inter Parfums, Inc. (2.88%), Prestige Consumer Healthcare Inc. (3.20%), Herbalife Ltd. (16.11%), USANA Health Sciences, Inc. (1.95%), Nu Skin Enterprises, Inc. (3.33%), Nature's Sunshine Products, Inc. (0.66%), Medifast, Inc. (30.42%), Veru Inc. (8.65%), Colgate-Palmolive (1.25%), Haleon plc (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Estée Lauder Companies stock? Short selling EL is an investing strategy that aims to generate trading profit from Estée Lauder Companies as its price is falling. EL shares are trading up $2.62 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Estée Lauder Companies? A short squeeze for Estée Lauder Companies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EL, which in turn drives the price of the stock up even further. How often is Estée Lauder Companies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EL, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: IPAR Short Interest PBH Short Interest HLF Short Interest USNA Short Interest NUS Short Interest NATR Short Interest MED Short Interest VERU Short Interest CL Short Interest HLN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Estée Lauder Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.